Cover Image

NKT cells - new players in CAR cell immunotherapy?

Low levels of peripheral blood natural killer T (NKT) cells in cancer patients and a favorable outcome associated with a high number of tumor-infiltrating NKT cells demonstrated in several studies indicated the important role of these immune cells in the antitumor response. With effective antitumor...

Full description

Saved in:
Bibliographic Details
Main Authors: Kriegsmann, Katharina (Author) , Kriegsmann, Mark (Author) , Bergwelt‐Baildon, Michael von (Author) , Cremer, Martin (Author) , Witzens-Harig, Mathias (Author)
Format: Article (Journal)
Language:English
Published: 06 September 2018
In: European journal of haematology
Year: 2018, Volume: 101, Issue: 6, Pages: 750-757
ISSN:1600-0609
DOI:10.1111/ejh.13170
Online Access:Verlag, Volltext: https://doi.org/10.1111/ejh.13170
Verlag: https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13170
Get full text
Author Notes:Katharina Kriegsmann, Mark Kriegsmann, Michael von Bergwelt‐Baildon, Martin Cremer, Mathias Witzens‐Harig
Description
Summary:Low levels of peripheral blood natural killer T (NKT) cells in cancer patients and a favorable outcome associated with a high number of tumor-infiltrating NKT cells demonstrated in several studies indicated the important role of these immune cells in the antitumor response. With effective antitumor immunity via direct tumor lysis, cytokine modulation of effector cells and regulation of immunosuppressive cells, type I NKT cells display interesting features/properties for the rapidly developing chimeric antigen receptor (CAR) technology. Due to their restriction to the monomorphic HLA-like molecule CD1d, but not to the polymorphic human leukocyte antigen (HLA), NKT CAR cells show potential for enabling autologous and allogeneic/off-the-shelf cancer immunotherapy. Promising results were obtained in preclinical NKT CAR cell studies, but clinical trials have not yet been conducted. In this review, we summarize the biological features of NKT cells, their role in antitumor immunity and recent advances in the development of NKT CAR cells.
Item Description:Gesehen am 29.10.2019
Physical Description:Online Resource
ISSN:1600-0609
DOI:10.1111/ejh.13170

Similar Items